Karyopharm Therapeutics
KPTI
#9087
Rank
โ‚น6.81 B
Marketcap
โ‚น53.99
Share price
-2.25%
Change (1 day)
-20.84%
Change (1 year)

Revenue for Karyopharm Therapeutics (KPTI)

Revenue in 2024 (TTM): โ‚น12.38 Billion

According to Karyopharm Therapeutics 's latest financial reports the company's current revenue (TTM ) is โ‚น12.62 Billion. In 2023 the company made a revenue of โ‚น12.15 Billion a decrease over the revenue in the year 2022 that were of โ‚น12.99 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Karyopharm Therapeutics from 2013 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚น12.38 B1.88%
2023 โ‚น12.15 B-6.47%
2022 โ‚น12.99 B-16.77%
2021 โ‚น15.61 B97.57%
2020 โ‚น7.90 B171.07%
2019 โ‚น2.91 B37.48%
2018 โ‚น2.12 B1969.83%
2017 โ‚น0.10 B879.27%
2016 โ‚น10.46 M-37.01%
2015 โ‚น16.61 M14.97%
2014 โ‚น14.45 M-39.56%
2013 โ‚น23.9 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚น5.371 T 42,458.04%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น4.033 T 31,855.24%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น3.504 T 27,666.40%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น176.98 B 1,302.30%๐Ÿ‡บ๐Ÿ‡ธ USA